|
ETNK1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.04050000229827E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.56009999996432E-06 |
| Normal-vs-Stage2 |
2.16889999999914E-05 |
| Normal-vs-Stage3 |
2.45889997252391E-09 |
| Normal-vs-Stage4 |
1.18599999998636E-06 |
| Stage1-vs-Stage2 |
3.217200E-01 |
| Stage1-vs-Stage3 |
1.220410E-02 |
| Stage1-vs-Stage4 |
5.928100E-02 |
| Stage2-vs-Stage3 |
4.293400E-01 |
| Stage2-vs-Stage4 |
5.067600E-01 |
| Stage3-vs-Stage4 |
9.738200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.22159999893512E-08 |
| Normal-vs-AfricanAmerican |
5.622500E-03 |
| Normal-vs-Asian |
1.95244999999789E-05 |
| Caucasian-vs-AfricanAmerican |
5.612800E-01 |
| Caucasian-vs-Asian |
9.289800E-01 |
| AfricanAmerican-vs-Asian |
6.508000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.48090000040568E-07 |
| Normal-vs-Female |
9.06539999734335E-08 |
| Male-vs-Female |
7.917400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.21369999999776E-05 |
| Normal-vs-Age(41-60Yrs) |
1.28789999997991E-07 |
| Normal-vs-Age(61-80Yrs) |
2.32850000392304E-08 |
| Normal-vs-Age(81-100Yrs) |
1.878380E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.362200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.382000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.306800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.651600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.266000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.990200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.986000E-04 |
| Classical-VS-Follicular |
6.556400E-01 |
| Classical-VS-Other |
8.611400E-01 |
| Classical-VS-Normal |
7.98570000015708E-07 |
| Tall-VS-Follicular |
6.395600E-03 |
| Tall-VS-Other |
1.342170E-01 |
| Tall-VS-Normal |
9.33520039048119E-10 |
| Follicular-VS-Other |
9.837600E-01 |
| Follicular-VS-Normal |
4.34150000000466E-05 |
| Other-VS-Normal |
4.643700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.87229999948357E-07 |
| Normal-vs-N1 |
4.92839999921557E-08 |
| N0-vs-N1 |
1.639200E-01 |
|
|
